121 related articles for article (PubMed ID: 30663139)
1. Addressable Peptide Self-Assembly on the Cancer Cell Membrane for Sensitizing Chemotherapy of Renal Cell Carcinoma.
Wang Z; An HW; Hou D; Wang M; Zeng X; Zheng R; Wang L; Wang K; Wang H; Xu W
Adv Mater; 2019 Mar; 31(11):e1807175. PubMed ID: 30663139
[TBL] [Abstract][Full Text] [Related]
2. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of c-FLIPL expression by miRNA-708 increases the sensitivity of renal cancer cells to anti-cancer drugs.
Kim EA; Kim SW; Nam J; Sung EG; Song IH; Kim JY; Kwon TK; Lee TJ
Oncotarget; 2016 May; 7(22):31832-46. PubMed ID: 27092874
[TBL] [Abstract][Full Text] [Related]
4. A new molecular targeted therapeutic approach for renal cell carcinoma with a p16 functional peptide using a novel transporter system.
Zennami K; Yoshikawa K; Kondo E; Nakamura K; Upsilonamada Y; De Velasco MA; Tanaka M; Uemura H; Shimazui T; Akaza H; Saga S; Ueda R; Honda N
Oncol Rep; 2011 Aug; 26(2):327-33. PubMed ID: 21567093
[TBL] [Abstract][Full Text] [Related]
5. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
6. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
Chen D; Sun X; Zhang X; Cao J
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
[TBL] [Abstract][Full Text] [Related]
7. Dual-targeting hybrid peptide-conjugated doxorubicin for drug resistance reversal in breast cancer.
Sheng Y; You Y; Chen Y
Int J Pharm; 2016 Oct; 512(1):1-13. PubMed ID: 27521706
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
9. Engineering Anticancer Amphipathic Peptide-Dendronized Compounds for Highly-Efficient Plasma/Organelle Membrane Perturbation and Multidrug Resistance Reversal.
Zhang X; Li Y; Hu C; Wu Y; Zhong D; Xu X; Gu Z
ACS Appl Mater Interfaces; 2018 Sep; 10(37):30952-30962. PubMed ID: 30088909
[TBL] [Abstract][Full Text] [Related]
10. Nuclear-targeting TAT-PEG-Asp8-doxorubicin polymeric nanoassembly to overcome drug-resistant colon cancer.
Pan ZZ; Wang HY; Zhang M; Lin TT; Zhang WY; Zhao PF; Tang YS; Xiong Y; Zeng YE; Huang YZ
Acta Pharmacol Sin; 2016 Aug; 37(8):1110-20. PubMed ID: 27292613
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-Triggered Morphological Transition of Peptide Nanostructures for Tumor-Targeted Drug Delivery and Enhanced Cancer Therapy.
Cao M; Lu S; Wang N; Xu H; Cox H; Li R; Waigh T; Han Y; Wang Y; Lu JR
ACS Appl Mater Interfaces; 2019 May; 11(18):16357-16366. PubMed ID: 30991000
[TBL] [Abstract][Full Text] [Related]
13. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
[TBL] [Abstract][Full Text] [Related]
14. Targeted chemotherapy with cytotoxic bombesin analogue AN-215 can overcome chemoresistance in experimental renal cell carcinomas.
Keller G; Schally AV; Nagy A; Halmos G; Baker B; Engel JB
Cancer; 2005 Nov; 104(10):2266-74. PubMed ID: 16211544
[TBL] [Abstract][Full Text] [Related]
15. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L
Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436
[TBL] [Abstract][Full Text] [Related]
16. Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity.
Wang L; Li C; Wang J; Yang G; Lv Y; Fu B; Jian L; Ma J; Yu J; Yang Z; Wu P; Li G; Liu X; Kang Z; Wang Z; Wang L; Wang H; Xu W
Adv Mater; 2022 Oct; 34(43):e2203518. PubMed ID: 36004775
[TBL] [Abstract][Full Text] [Related]
17. Membrane activity of a supramolecular peptide-based chemotherapeutic enhancer.
Xu D; Jiang L; DeRidder L; Elmore B; Bukhari M; Wei Q; Samways DS; Dong H
Mol Biosyst; 2016 Aug; 12(9):2695-9. PubMed ID: 27397555
[TBL] [Abstract][Full Text] [Related]
18. Coupling the near-infrared fluorescent dye IR-780 with cabazitaxel makes renal cell carcinoma chemotherapy possible.
Zheng Y; Lan T; Wei D; Zhang G; Hou G; Yuan J; Yan F; Wang F; Meng P; Yang X; Chen G; Zhu Z; Lu Z; He W; Yuan J
Biomed Pharmacother; 2019 Aug; 116():109001. PubMed ID: 31146114
[TBL] [Abstract][Full Text] [Related]
19. Silibinin inhibits the invasion and migration of renal carcinoma 786-O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5-fluorouracil and paclitaxel.
Chang HR; Chen PN; Yang SF; Sun YS; Wu SW; Hung TW; Lian JD; Chu SC; Hsieh YS
Mol Carcinog; 2011 Oct; 50(10):811-23. PubMed ID: 21574189
[TBL] [Abstract][Full Text] [Related]
20. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
